PAN-NUCLEOSIDE AND NONNUCLEOSIDE RESISTANT STRAINS AFTER SEQUENTIAL THERAPY WITH NRTIS AND NNRTI

S Sprecher; P Hermans; JC Schmit; Jacqueline Cogniaux; C Vanvaeck; De Clercq Erik; Anne‐Mieke Vandamme; Nathan Clumeck

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1994

Intensive Sequential Therapy for VAD-Resistant Multiple Myeloma

Meletios A Dimopoulos, Donna M. Weber, Jeane P. Hester, Kay Delasalle, Richard Champlin, Raymond Alexanian

Article1996

Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors

Jan Balzarini, Heidi Pelemans, Anna Karlsson, De Clercq Erik, Jőrg‐Peter Kleim

Letter2000

Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir

Kristel Van Laethem, Myriam Witvrouw, Jan Balzarini, Jean‐Claude Schmit, S Sprecher, Philippe Hermans, Manuel Leal, Thomas Harrer, Lı́dia Ruiz, Bonaventura Clotet, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme

Article2002

Susceptibilities of several drug-resistant varicella-zoster virus (VZV) strains to bicyclic pyrimidine nucleoside analogues (BCNAs)

Graciela Andreï, Rebecca Sienaert, Lieve Naesens, De Clercq Erik, Christopher McGuigan, Jan Balzarini, Robert Snoeck

Article2021

Sequential Therapy for Hepatocellular Carcinoma after Failure of Atezolizumab plus Bevacizumab Combination Therapy

Masatoshi Kudo